Publication | Closed Access

POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINE

Functional SelectivityMedicineNeuropharmacologyNeurologyNeurosciencePharmacology